Енжерикс B

Енжерикс B is an injectable vaccine containing hepatitis B surface antigen for active immunization against hepatitis B virus. This recombinant DNA vaccine helps prevent infection by stimulating the body's immune response. Suitable for adults and children.

Енжерикс B is used to protect against infection caused by the hepatitis B virus. It is indicated for active immunization of individuals at risk of exposure, including newborns, healthcare workers, and travelers to regions with high hepatitis B prevalence. The vaccine is also used in pre-exposure and post-exposure prophylaxis scenarios.

After administration, the vaccine stimulates the immune system to produce antibodies against the hepatitis B surface antigen. This immune response helps the body recognize and fight future hepatitis B infections. Protection typically develops over several weeks following the full vaccination series.

Store the vaccine refrigerated between 2°C and 8°C (36°F and 46°F) and protect it from light. Do not freeze. Before use, inspect the vial or syringe for particles or discoloration. Ensure proper disposal of used needles and syringes in accordance with local regulations.

Concurrent administration with other vaccines is generally safe, but separate injection sites should be used. Immunosuppressive therapies may reduce the vaccine's effectiveness. Consult a healthcare provider before receiving live vaccines or undergoing immunosuppressive treatment.